Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > INAB In8bio > Detailed Quotes

INAB In8bio

2.140
-0.025-1.15%
Trading Session 10/05 12:20 ET
High
2.225
Open
2.090
Turnover
36.66K
Low
2.090
Pre Close
2.165
Volume
17.23K
Market Cap
52.38M
P/E(TTM)
Loss
52wk High
9.424
Shares
24.48M
P/E(Static)
Loss
52wk Low
1.710
Float Cap
15.28M
Bid/Ask %
66.67%
Historical High
10.319
Shs Float
7.14M
Volume Ratio
0.65
Historical Low
1.710
Dividend TTM
--
Div Yield TTM
--
P/B
1.97
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.24%
Amplitude
6.24%
Avg Price
2.127
Lot Size
1
Float Cap
15.28M
Bid/Ask %
66.67%
Historical High
10.319
Shs Float
7.14M
Volume Ratio
0.65
Historical Low
1.710
Dividend TTM
--
P/B
1.97
Dividend LFY
--
Turnover Ratio
0.24%
Amplitude
6.24%
Avg Price
2.127
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. Lamb and William T. Ho on February 8, 2016 and is headquartered in New York, NY.
CEO: Mr. William Ho
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...